Benefit of primary prophylactic ICD-therapy in nonischemic compared to ischemic cardiomyopathy with and without cardiac resynchronization therapy

17 March 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Doctor Thomas Kleemann

Klinikum Ludwigshafen, Ludwigshafen (Germany)

26 More presentations in this session

Presentation thumbnail

Statistical ranking of electromechanical dyssynchrony parameters for cardiac resynchronisation therapy

Doctor S. Cazeau (Paris, FR)

Abstract Slides

Presentation thumbnail

Left ventricular scar predicts remodeling in patients undergoing cardiac resynchronisation therapy - A retrospective analysis from a large tertiary centre

Ms K. Thomasson (Luton, GB)

Abstract Slides

Presentation thumbnail

Lead positioning for cardiac resynchronization therapy, a randomized trial comparing an active fixation bipolar left ventricular lead and a passive fixation quadripolar lead

Mr H. Keilegavlen (Bergen, NO)

Abstract Slides

Presentation thumbnail

Clinical outcome of cardiac resynchronization therapy in patients randomized to an active fixation bipolar left ventricular lead versus a passive quadripolar lead

Mr H. Keilegavlen (Bergen, NO)

Abstract Slides

Presentation thumbnail

Heart failure hospitalizations and associated costs in ICD/CRT-D recipients following device replacement or upgrade: insights from the DECODE registry

Doctor V. Zaca' (Siena, IT)

Access the full session

Session thumbnail

Poster session 3 - Cardiac Resynchronization Therapy

The Event

EHRA 2019

17 March - 19 March 2019

You may be interested in

Congress Presentation

Conduction system pacing in the current treatment of HFrEF patients

Congress Presentation

Device therapy: how to identify responders?

Congress Presentation

Cardiac resynchronisation therapy

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources